Manning & Napier Advisors LLC Takes Position in Molina Healthcare, Inc $MOH

Manning & Napier Advisors LLC bought a new position in shares of Molina Healthcare, Inc (NYSE:MOH) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 663,669 shares of the company’s stock, valued at approximately $152,339,000. Molina Healthcare accounts for about 2.0% of Manning & Napier Advisors LLC’s holdings, making the stock its 18th largest holding.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in MOH. Elevation Wealth Partners LLC raised its stake in Molina Healthcare by 118.2% during the 2nd quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock valued at $33,000 after acquiring an additional 78 shares during the last quarter. Torren Management LLC purchased a new position in shares of Molina Healthcare in the 4th quarter valued at approximately $26,000. MUFG Securities EMEA plc purchased a new position in shares of Molina Healthcare in the 2nd quarter valued at approximately $48,000. Global Retirement Partners LLC acquired a new position in shares of Molina Healthcare in the second quarter valued at approximately $39,000. Finally, Quarry LP purchased a new stake in shares of Molina Healthcare during the fourth quarter worth approximately $32,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on MOH. Royal Bank Of Canada decreased their price target on Molina Healthcare from $248.00 to $218.00 and set a “sector perform” rating for the company in a report on Friday, July 24th. Weiss Ratings cut shares of Molina Healthcare from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, July 24th. Mizuho set a $215.00 price objective on shares of Molina Healthcare in a research report on Monday, June 8th. Sanford C. Bernstein set a $286.00 target price on shares of Molina Healthcare in a research note on Monday, July 13th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Molina Healthcare in a report on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $202.44.

Molina Healthcare Price Performance

Shares of NYSE MOH opened at $198.65 on Tuesday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.68 and a current ratio of 1.68. Molina Healthcare, Inc has a one year low of $121.06 and a one year high of $244.89. The firm has a market capitalization of $10.37 billion, a P/E ratio of -1,103.57, a PEG ratio of 28.70 and a beta of 0.75. The company’s fifty day moving average is $211.20 and its two-hundred day moving average is $178.68.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, beating the consensus estimate of $1.39 by $0.12. The firm had revenue of $10.87 billion during the quarter, compared to analysts’ expectations of $10.83 billion. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The business’s revenue for the quarter was down 4.8% compared to the same quarter last year. During the same quarter last year, the business earned $5.48 earnings per share. Analysts forecast that Molina Healthcare, Inc will post 5.29 EPS for the current fiscal year.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.